Abridge

🎉 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁: Abridge welcomes Mario Queiroz, award-winning former Google and Hinge Health technology executive leader, to accelerate enterprise growth and strategic innovation as Chief Product Officer. 🧑💻 Former GM and VP of Product Management for leading Google products with hundreds of millions of users. 📺 Created, launched, and scaled Chromecast globally, one of Google’s best-selling devices ever—over 100M sold, named TIME “Gadget of the Year.” 🏥 Former Chief Product Officer at Hinge Health, overseeing enterprise-wide R&D, consumer marketing, and hardware devices—used by hundreds of the largest enterprise customers and millions of patients. 🥳 One of Fast Company’s Most Creative People in Business. 𝗤𝘂𝗲𝗶𝗿𝗼𝘇 𝗶𝘀 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗺𝗮𝗸𝗶𝗻𝗴 𝗮𝗻 𝗶𝗺𝗽𝗮𝗰𝘁 𝗮𝘁 𝗔𝗯𝗿𝗶𝗱𝗴𝗲: “He’s overseen product management, design, engineering, multiple products concurrently…he’s already started to think through all the various strategic challenges.” — Zachary Lipton, Abridge Chief Technology and Chief Science Officer “The focus on user obsession and how to create the best possible user experience, this is something Mario excels at.” — Julia Chou, Abridge Chief Operating Officer Watch the video to learn more about Queiroz and his vision for the Abridge platform.

Temple is dedicated to reducing administrative burdens to support our physicians so they can focus on what matters most—patient centered care and maintaining their own work-life balance. The streamlined design of clinical documentation via this ambient listening technology allows our physicians to spend less time on note taking—preventing the dreaded need to bring work home—and more time engaging directly with patients, maintaining eye contact, fostering meaningful conversations, and building stronger relationships. This kind of focused interaction leads to better outcomes and a more fulfilling experience for both patients and providers.   Dean Amy Goldberg, MD, FACS and I are committed to finding effective solutions that make our physicians' work more sustainable and rewarding, so they can continue delivering the excellent care our patients deserve.

🙏 A big thank you to AMIA (American Medical Informatics Association) for hosting an inspiring Symposium! The Abridge team enjoyed connecting with many of you and sharing insights about our enterprise-grade generative AI platform. A key moment was our panel, Scaling AI for Enterprise: Data & Impact Stories From Medical Informatics Leaders. Some highlights: ❤️🩹 𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗻 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲: Sachin D. Shah, CMIO at UChicago Medicine, shared how Abridge has driven a 3.6 percentage point increase in a critical patient satisfaction Press Ganey score. 🩺 𝗕𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝗝𝗼𝘆 𝗕𝗮𝗰𝗸 𝘁𝗼 𝗖𝗹𝗶𝗻𝗶𝗰𝗶𝗮𝗻𝘀: Sarah Rush, CMIO at Akron Children's, noted, “Conversations have changed—clinicians can now connect more deeply with patients, freed from the cognitive load of documentation. It’s making a real difference in clinician satisfaction and patient care.” 🔄 𝗨𝘀𝗲𝗿-𝗖𝗲𝗻𝘁𝗲𝗿𝗲𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: Gregory Ator MD, from the University of Kansas Medical Center, reflected on how our partnership and responsive feedback cycles have continually enhanced clinician experience, evident in steadily rising user ratings. Abridge CEO Shivdev Rao also fielded questions from a packed audience, sharing the long-term vision for how generative AI will transform healthcare to improve clinician and patient experiences. Thank you again to all who joined us!

🌁 We're excited to be at the AMIA (American Medical Informatics Association) Symposium in SF on Nov 10-12! Visit us at Booth #403 in the Exhibit Hall, and join our panel discussion below. “𝗦𝗰𝗮𝗹𝗶𝗻𝗴 𝗔𝗜 𝗳𝗼𝗿 𝗘𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲: 𝗗𝗮𝘁𝗮 & 𝗜𝗺𝗽𝗮𝗰𝘁 𝗦𝘁𝗼𝗿𝗶𝗲𝘀 𝗙𝗿𝗼𝗺 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗰𝘀 𝗟𝗲𝗮𝗱𝗲𝗿𝘀.” 📅 Date: November 11 at 3:30 PM 📍 Location: Franciscan D 🎤 Speakers: Shivdev Rao, Abridge | Sachin D. Shah, UChicago Medicine | Sarah Rush, Akron Children's | Gregory Ator MD, University of Kansas Medical Center Hear from leaders across the country who have rigorously evaluated and implemented enterprise-grade AI for clinical documentation at their hospital systems. Through data-driven case studies and candid testimonials, learn how this technology is reducing cognitive load and streamlining care at large health systems, benefiting clinicians and patients alike. We hope to see you there!

📣 𝗡𝗲𝘄 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 𝘁𝗼 𝗔𝗜 𝗺𝗼𝗱𝗲𝗹𝘀 powering Abridge’s automatic speech recognition (ASR): improved medication recognition and expanded multilingual capabilities. Continuous feedback from stakeholders drives our culture of innovation at Abridge, inspiring new AI research efforts and rapid product delivery. Today, we’re excited to share improvements to our AI systems: • 28 languages with state-of-the-art ASR accuracy, outperforming all other open-source and commercial offerings on medical speech, including the 16 most frequently spoken in U.S. healthcare settings • 11% relative reduction in word error rate (WER) in Spanish • 3% reduction in WER for English clinical conversations • 41% fewer misspellings on new FDA-approved medications compared to previous model, and 81% fewer errors than Google’s Medical Conversation speech engine These improvements align with our commitment to continuously evaluate and enhance our world-class ASR and note generation products, while fostering inclusivity, accessibility, and equity by empowering more patients and doctors to engage in their preferred languages. 💡Read our whitepaper, Pioneering the Science of AI Evaluation, for more details about these updates: https://lnkd.in/edBFAXdU

HLTH Inc. 2024 was an incredible experience for Abridge, packed with memorable highlights. Here are four standout moments that made it truly special: 1️⃣ Celebrating awards and partnerships: NVIDIA and Bessemer Venture Partners joined Abridge at an event to celebrate impactful partnerships. 2️⃣ Sharing outcomes: Dr. Denton Shanks DO MPH from University of Kansas Medical Center and Dr. Justin Stinnett-Donnelly from the The University of Vermont Health Network explained Abridge's positive impact on their teams. 3️⃣ Discussing AI technology: Dr. Shivdev Rao, Abridge CEO and Founder, spoke on the panel 'Beware of AI-Washing' and emphasized Abridge’s science-and research-focused approach. 4️⃣ Earning recognition: Abridge was proud to be the first-ever generative AI company to win a triple top five ranking in the 2024 KLAS Research Emerging Technology Solution awards, including No. 1 in Improve Clinician Experience. HLTH energized us to continue building and growing a world-class healthcare AI platform that scales for complex healthcare systems—and we can’t wait to see what next year will bring!

📣 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁: 𝗔𝗯𝗿𝗶𝗱𝗴𝗲 𝗮𝗻𝗱 OpenNotes 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝗼𝗻 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘁𝗼 𝗘𝗻𝗵𝗮𝗻𝗰𝗲 𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗡𝗼𝘁𝗲𝘀 Today, we’re announcing a partnership with OpenNotes at Beth Israel Deaconess Medical Center that will enhance patient notes by bringing patient-clinician conversations to the forefront of research. OpenNotes is leading a study using focus groups to evaluate Abridge’s AI-generated Patient Visit Summaries. These notes are written based on the clinician-patient conversation in real-time at an 8th-grade reading level. The insights from the study will be used to enhance these notes to better meet the needs of some of the most important healthcare stakeholders: clinicians, patients, and patient advocates. This partnership is part of the OpenNotes Lab, an initiative fostering collaboration between patients and clinicians in developing AI-powered tools. OpenNotes joins other leading healthcare organizations that enrich Abridge’s generative AI platform with scientific research and deep technology integrations. 💬 "This research collaboration with OpenNotes will harness the power of actual patient conversations in informing the next generation of visit summaries, an invaluable tool in keeping patients engaged with their care." – Dr. Shivdev Rao, CEO and Founder of Abridge. Learn more: https://lnkd.in/eVvVJpZa

🎤𝗟𝗜𝗩𝗘 𝗮𝘁 CHIME 𝗙𝗮𝗹𝗹 𝗙𝗼𝗿𝘂𝗺: 𝗘𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲-𝗚𝗿𝗮𝗱𝗲 𝗔𝗜 𝗜𝗺𝗽𝗮𝗰𝘁 𝗗𝗮𝘁𝗮 𝗮𝗻𝗱 𝗨𝗻𝗳𝗶𝗹𝘁𝗲𝗿𝗲𝗱 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀 (𝟭𝟭/𝟲) Connect with Abridge at CHIME Fall Forum Nov 4-8! Don’t miss Shivdev Rao, CEO and Founder of Abridge, in conversation with Muhammad S. of Reid Health and Veena Jones of Sutter Health for the Elite Exchange session, "Scaling Enterprise-Grade Generative AI: Impact Data & Unfiltered Perspectives,” on Wednesday, Nov 6 at 3:45PM in Pacific Ballroom #21. Hear from healthcare leaders who have successfully implemented enterprise-grade AI for clinical documentation, and discover how this technology is reducing cognitive load for clinicians from California to Indiana across a diverse range of specialties, languages, and workflows.

At HLTH last week, we were honored to receive three KLAS Research Emerging Solutions Top 20 Awards, including No. 1 for Improving Clinician Experience. We celebrated this meaningful milestone at an Abridge event, where Kimberly Powell, NVIDIA's VP/GM of Healthcare, joined us on stage to highlight how technology and strong partnerships will continue to drive our mission forward.

🎉𝗔𝗯𝗿𝗶𝗱𝗴𝗲 𝗻𝗮𝗺𝗲𝗱 𝘁𝗼 TIME’𝘀 𝗕𝗲𝘀𝘁 𝗜𝗻𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝘀 𝗼𝗳 𝟮𝟬𝟮𝟰 𝗹𝗶𝘀𝘁 🎉 Since 2018, Abridge has been assembling a team of world-class clinicians and scientists with the goal of solving one of the most significant problems in healthcare: clinician burnout caused by the burden of repetitive administrative work. Our answer to this challenge is Abridge’s enterprise-grade AI technology—built to scale for the needs of a diverse range of the most complex healthcare systems, often academic and innovative institutions. These organizations hold us to the highest standards, inspiring a culture at Abridge centered around invention, scalability, and exceptional care. That is why we want to share the spotlight today with our partners. We thank you for the privilege of our deep and close collaboration—gathering and incorporating feedback and endlessly iterating with us to better support your needs. 🙏 This recognition from TIME underscores the progress towards our joint vision—steadily improving the lives of clinicians so they can better focus on their patients. Read more about all the TIME Best Inventions: https://lnkd.in/e66KFqmj